Invention Grant
US09279160B2 DNA-based methods for clone-specific identification of staphylococcus aureus
有权
用于克隆特异性鉴定金黄色葡萄球菌的基于DNA的方法
- Patent Title: DNA-based methods for clone-specific identification of staphylococcus aureus
- Patent Title (中): 用于克隆特异性鉴定金黄色葡萄球菌的基于DNA的方法
-
Application No.: US13379499Application Date: 2010-06-17
-
Publication No.: US09279160B2Publication Date: 2016-03-08
- Inventor: Marc Stegger , Luca Guardabassi , Jodi Lindsay
- Applicant: Marc Stegger , Luca Guardabassi , Jodi Lindsay
- Applicant Address: DK Copenhagen S DK Copenhagen K GB London
- Assignee: Statens Serum Institut,The University of Copenhagen,St Georges Hospital Medical School
- Current Assignee: Statens Serum Institut,The University of Copenhagen,St Georges Hospital Medical School
- Current Assignee Address: DK Copenhagen S DK Copenhagen K GB London
- Agency: Howson & Howson LLP
- Priority: DK200900767 20090622
- International Application: PCT/DK2010/000093 WO 20100617
- International Announcement: WO2010/149159 WO 20101229
- Main IPC: C12P19/34
- IPC: C12P19/34 ; C12Q1/68

Abstract:
MRSA CC398 is a clone of S. aureus that has recently emerged in pigs and other domestic animals worldwide. As any other MRSA, the clone displays high levels of antibiotic resistance and poses a serious threat to human health because of the risk of antibiotic treatment failure in human patients. We developed a new diagnostic test for identification of MRSA CC398 using a single one-step PCR that is very easily performed within a few hours. The test is based on the principle that clonal differences within S. aureus are reflected in the sequence of a gene (sau1hsdS1) located on the chromosome of this bacterial species. Accordingly, such a gene represents an optimal target for S. aureus and MRSA identification at the clone level. The test includes detection of the gene conferring methicillin resistance (mecA), therefore allowing rapid discrimination between methicillin-susceptible and methicillin-resistant variants of the clone. A preliminary validation of the test was performed on a collection of CC398 and non-CC398 strains, resulting in 100% sensitivity and 100% specificity. The test can be combined to real-time PCR technology to further reduce simplify the test performance as well as to allow quantification of the target MRSA clone in biological specimens. The invention has important applications related to surveillance and control of MRSA CC398 in humans, animals and food products.
Public/Granted literature
- US20120208714A1 DNA-BASED METHODS FOR CLONE-SPECIFIC IDENTIFICATION OF STAPHYLOCOCCUS AUREUS Public/Granted day:2012-08-16
Information query